Skip to content

GLUCOSE HEALTH, INC.: 10-Q filed 2017-08-21

What GLUCOSE HEALTH, INC. reported in its quarterly report filed 2017-08-21 (fiscal Q2 2017): 29 published measures, 78 facts as tagged in accession 0001477932-17-004075.

This filing

Form
10-Q (quarterly report)
Filed
2017-08-21
Fiscal period
fiscal Q2 2017
Accession
0001477932-17-004075 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All GLUCOSE HEALTH, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2017-06-3027,318USD
At 2016-12-3133,145USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2017-06-30476,607USD
At 2016-12-31528,592USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2017-06-30-449,289USD
At 2016-12-31-495,447USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2017-06-3018,313USD
At 2016-12-3120,542USD
At 2015-12-312,055USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2017-04-01 to 2017-06-3049,258USD91
2017-01-01 to 2017-06-3020,249USD181
2016-04-01 to 2016-06-30-87,370USD91
2016-01-01 to 2016-06-30-125,544USD182

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2017-01-01 to 2017-06-30-12,229USD181
2016-01-01 to 2016-06-30-97,782USD182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2017-01-01 to 2017-06-3010,000USD181
2016-01-01 to 2016-06-30123,500USD182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2017-06-30-6,227,388USD
At 2016-12-31-6,247,637USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2017-04-01 to 2017-06-303,718,155shares91
2017-01-01 to 2017-06-303,529,454shares181
2016-04-01 to 2016-06-302,587,301shares91
2016-01-01 to 2016-06-302,545,087shares182

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2017-04-01 to 2017-06-300.01USD/shares91
2017-01-01 to 2017-06-300.01USD/shares181
2016-04-01 to 2016-06-30-0.03USD/shares91
2016-01-01 to 2016-06-30-0.05USD/shares182

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2017-04-01 to 2017-06-3016,077USD91
2017-01-01 to 2017-06-30-12,236USD181
2016-04-01 to 2016-06-306,032USD91
2016-01-01 to 2016-06-30-6,243USD182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2017-06-3027,108USD
At 2016-12-3132,905USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2017-04-01 to 2017-06-305,096USD91
2017-01-01 to 2017-06-305,792USD181
2016-04-01 to 2016-06-3093,402USD91
2016-01-01 to 2016-06-30119,301USD182

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2017-06-30476,607USD
At 2016-12-31528,592USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2017-06-308,795USD
At 2016-12-3111,724USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2017-04-01 to 2017-06-3017,697USD91
2017-01-01 to 2017-06-3046,483USD181
2016-04-01 to 2016-06-3015,313USD91
2016-01-01 to 2016-06-3027,648USD182

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2017-06-300USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2017-04-01 to 2017-06-3033,774USD91
2017-01-01 to 2017-06-3034,247USD181
2016-04-01 to 2016-06-3021,345USD91
2016-01-01 to 2016-06-3021,405USD182

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2017-04-01 to 2017-06-30272USD91
2017-01-01 to 2017-06-3014,910USD181
2016-04-01 to 2016-06-30274,464USD91
2016-01-01 to 2016-06-30274,524USD182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2017-06-303,979,792shares
At 2016-12-313,312,273shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2017-06-30-75,278USD
At 2016-12-31-75,278USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2017-06-3037,997USD
At 2016-12-3138,631USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2017-04-01 to 2017-06-3049,258USD91
2017-01-01 to 2017-06-3020,249USD181
2016-04-01 to 2016-06-30-87,370USD91
2016-01-01 to 2016-06-30-125,544USD182

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2017-04-01 to 2017-06-307,557USD91
2017-01-01 to 2017-06-3020,047USD181
2016-04-01 to 2016-06-305,767USD91
2016-01-01 to 2016-06-308,684USD182

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2017-01-01 to 2017-06-3030USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2017-04-01 to 2017-06-3033,181USD91
2017-01-01 to 2017-06-3032,485USD181
2016-04-01 to 2016-06-30-93,402USD91
2016-01-01 to 2016-06-30-119,301USD182

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2017-01-01 to 2017-06-30221USD181
2016-01-01 to 2016-06-30165,196USD182

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2016-01-01 to 2016-06-30-60USD182

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2017-04-01 to 2017-06-3038,277USD91
2017-01-01 to 2017-06-3038,277USD181

Inspect the source

Entity
GLUCOSE HEALTH, INC. / CIK 0001420108
Captured
2026-09-20T08:03:02.532Z
SEC response SHA-256
ef83fc563a3cad26f7c669ccda854bb2594ebf064cf3fcc8412c49070ba2bb26

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001420108.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))